Related Experiment Video
Updated: Feb 27, 2026

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
Neuroprotection in progressive brain disorders
Ruth Djaldetti1, Nirit Lev, Eldad Melamed
1Department of Neurology, Rabin Medical Center (Beilinson Campus), Petah Tiqva, Israel. yhaimi@bezeqint.net
Abstract:
Progressive neurodegenerative disorders share common mechanisms of cell death, and in all likelihood multiple factors are involved in every disease. Therefore, several neuroprotective agents are being investigated with the purpose of slowing or preventing further deterioration of cell loss. These include experimental animal and clinical studies on the neuroprotective effects of caspase inhibitors, antioxidants, glutamate antagonists, anti-inflammatory agents and trophic factors in several neurodegenerative diseases. At present there is limited clinical evidence for direct neuroprotective effects against these diseases, but much effort is being invested in research on novel technologies and compounds.
Insights
Researchers are exploring neuroprotective agents to combat cell death in progressive neurodegenerative disorders. While clinical evidence is currently limited, ongoing research into novel compounds and technologies shows promise for future treatments.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Progressive neurodegenerative disorders involve shared cell death mechanisms.
- Multiple contributing factors are implicated in these complex diseases.
Purpose of the Study:
- To investigate neuroprotective agents for slowing or preventing cell loss.
- To review current experimental and clinical research on neuroprotection.
Main Methods:
- Review of experimental animal and clinical studies.
- Investigation of caspase inhibitors, antioxidants, glutamate antagonists, anti-inflammatory agents, and trophic factors.
Main Results:
- Limited clinical evidence currently exists for direct neuroprotective effects.
- Significant research efforts are focused on novel technologies and compounds.
Conclusions:
- Further research is needed to establish effective neuroprotective therapies.
- Novel approaches are under active investigation for neurodegenerative diseases.
More Related Videos
07:57An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices
Published on: April 11, 2018
09:48Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
Related Concept Videos
The Blood-brain Barrier
Neurogenesis and Regeneration of Nervous Tissue
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neuroplasticity
Neural Regulation